- Home
- Publications
- Publication Search
- Publication Details
Title
The Expanding Role of Therapeutic Antibodies
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 34, Issue 3, Pages 202-264
Publisher
Informa UK Limited
Online
2014-01-29
DOI
10.3109/08830185.2013.863304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OP0158 Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study
- (2014) I.B. McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
- (2013) S. H. Petersdorf et al. BLOOD
- Intravenous immunoglobulin and Alzheimer’s disease: what now?
- (2013) David A Loeffler Journal of Neuroinflammation
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- Pathogenesis and management of IBD—thinking outside the box
- (2013) Séverine Vermeire et al. Nature Reviews Gastroenterology & Hepatology
- Reclassification and the introduction of biologicals
- (2013) Cees G. M. Kallenberg Nature Reviews Nephrology
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Belimumab for Systemic Lupus Erythematosus
- (2013) Bevra Hannahs Hahn NEW ENGLAND JOURNAL OF MEDICINE
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
- (2013) C.M. Legendre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial†
- (2012) M. Reck et al. ANNALS OF ONCOLOGY
- Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160
- (2012) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
- (2012) Jacques-Eric Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
- (2012) Iuliana Shapira et al. ARTHRITIS AND RHEUMATISM
- Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy
- (2012) J. S. Orange et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review
- (2012) Dong Xue Wang et al. CLINICAL RHEUMATOLOGY
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Gemtuzumab Ozogamicin: Time to Resurrect?
- (2012) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Golimumab on Patient-reported Outcomes in Rheumatoid Arthritis: Results from the GO-FORWARD Study
- (2012) M. C. GENOVESE et al. JOURNAL OF RHEUMATOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
- (2012) Julien Zuber et al. Nature Reviews Nephrology
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab in a Patient with Dense-Deposit Disease
- (2012) Erica Daina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab and Refractory Membranoproliferative Glomerulonephritis
- (2012) Seetha Radhakrishnan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients
- (2011) S. C. Jordan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- (2011) M. D. Stegall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy
- (2011) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma
- (2011) RD May et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management
- (2011) Alessandra Vultaggio et al. Current Opinion in Allergy and Clinical Immunology
- Use of monoclonal antibodies in renal transplantation
- (2011) Martijn WF van den Hoogen et al. Immunotherapy
- L-proline-stabilized human IgG: Privigen®10% for intravenous use and Hizentra®20% for subcutaneous use
- (2011) Melvin Berger Immunotherapy
- Current and novel therapeutics in the treatment of systemic lupus erythematosus
- (2011) Cagri Yildirim-Toruner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria
- (2011) Sarbjit Saini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study
- (2011) Isabella Quinti et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: A retrospective analysis
- (2011) Giorgio Berlot et al. JOURNAL OF CRITICAL CARE
- Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
- (2011) M. Morigi et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Emerging antibody combinations in oncology
- (2011) Stephen J. Demarest et al. mAbs
- Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
- (2011) Jody D. Berry et al. New Biotechnology
- Antibodies in oncology
- (2011) Vinochani Pillay et al. New Biotechnology
- Treatment of Neonatal Sepsis with Intravenous Immune Globulin
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
- (2011) Phillip Scheinberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
- (2010) E. Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
- (2010) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application
- (2010) Maria Giovanna Danieli et al. AUTOIMMUNITY REVIEWS
- HCV infection in patients with primary defects of immunoglobulin production
- (2010) I. QUINTI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
- (2010) R. Gustafson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The other side of immunoglobulin G: suppressor of inflammation
- (2010) S. Aschermann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies
- (2010) Jordan S. Orange et al. CLINICAL IMMUNOLOGY
- Bevacizumab
- (2010) Marit D. Moen DRUGS
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)
- (2010) Fereydoun DAVATCHI et al. International Journal of Rheumatic Diseases
- Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years
- (2010) Mary Lucas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
- (2010) Marc Massanari et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders
- (2010) Mark Ballow JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunomodulation by Intravenous Immunoglobulin: Role of Regulatory T Cells
- (2010) Mohan S. Maddur et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels
- (2010) Sylvain Thépot et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
- (2010) John B. Hagan et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Immunomodulatory Therapy to Achieve Maximum Efficacy: Doses, Monitoring, Compliance, and Self-infusion at Home
- (2010) Mary Lucas et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma
- (2010) Brian O’Nuallain et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
- (2010) Marc Peeters et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
- (2010) Gilles Salles et al. LANCET
- Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin/antiviral regimen?
- (2010) Peter W. Angus et al. LIVER TRANSPLANTATION
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of respiratory syncytial virus with palivizumab: a systematic review
- (2010) Jia Hu et al. World Journal of Pediatrics
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study
- (2009) Arthur Kavanaugh et al. ARTHRITIS AND RHEUMATISM
- Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
- (2009) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease
- (2009) A. Roth et al. BLOOD
- Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
- (2009) L. Fong et al. CANCER RESEARCH
- Engineered therapeutic antibodies with improved effector functions
- (2009) Tsuguo Kubota et al. CANCER SCIENCE
- Intravenous immunoglobulins - understanding properties and mechanisms
- (2009) A. Durandy et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial
- (2009) T. Harbo et al. EUROPEAN JOURNAL OF NEUROLOGY
- Monoclonal antibody-induced cytokine-release syndrome
- (2009) Peter J Bugelski et al. Expert Review of Clinical Immunology
- Intravenous Immunoglobulin and Anti-RhD Therapy in the Management of Immune Thrombocytopenia
- (2009) Nichola Cooper HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
- (2009) Patrick J. Brennan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Subcutaneous immunoglobulin therapy for multifocal motor neuropathy
- (2009) Filip Eftimov et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside
- (2009) G Zandman-Goddard et al. LUPUS
- Scleromyxedema
- (2009) Marissa Blum et al. MEDICINE
- IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
- (2009) H. Fillit et al. NEUROLOGY
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raxibacumab for the Treatment of Inhalational Anthrax
- (2009) Thi-Sau Migone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy
- (2009) Dinesh Khanna et al. OPHTHALMOLOGY
- Unlabeled uses of intravenous immune globulin
- (2008) H. Leong et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
- (2008) J Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of Neuromyelitis Optica With Rituximab
- (2008) ARCHIVES OF NEUROLOGY
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
- (2008) Robert D. Inman et al. ARTHRITIS AND RHEUMATISM
- Preparation and use of therapeutic antibodies primarily of human origin
- (2008) E. Richard Stiehm et al. BIOLOGICALS
- Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma
- (2008) M. V. Kopp et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes
- (2008) Francisco A. Bonilla IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu
- (2008) Alessandro D. Santin et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection
- (2008) Vincent R. Bonagura et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of chronic autoimmune urticaria with omalizumab
- (2008) Allen P. Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
- (2008) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
- (2008) Robert Marcus et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Therapies for COPD
- (2008) Uma Yasothan et al. NATURE REVIEWS DRUG DISCOVERY
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- The Antiinflammatory IgG
- (2008) Srini V. Kaveri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a receptor required for the anti-inflammatory activity of IVIG
- (2008) R. M. Anthony et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
- Modulation of the cellular immune system by intravenous immunoglobulin
- (2008) Thanyalak Tha-In et al. TRENDS IN IMMUNOLOGY
- Subcutaneous immunoglobulin infusion: A new therapeutic option in chronic inflammatory demyelinating polyneuropathy
- (2007) De-Hyung Lee et al. MUSCLE & NERVE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now